FDA has approved marketing approval of a device -- the first of its kind -- that can help provide patients with relief from opioid withdrawal systems, the agency announced Wednesday (Nov. 15). The approval aligns with the agency’s efforts to find alternatives to opioids for pain management and speed access to opioid addiction treatment therapies, as well as its search for medical device alternatives to opioids -- something that FDA Commissioner Scott Gottlieb talked about during his confirmation hearing. Innovative...